Because cilostazol and probucol both increase HO-1 expression and have antioxidant properties, we hypothesized that the combination of low doses of these two drugs may exert synergistic effects on mitochondrial biogenesis via increasing the production and activity of HO-1 in a HepG2 human hepatoma cell line. This evidence concerns the gene HMOX1 and hepatocellular carcinoma.